Robitussin DM is a popular over-the-counter medication used to treat coughs and colds. It contains two active ingredients: dextromethorphan, an antitussive that helps suppress coughs, and guaifenesin, an expectorant that helps thin and loosen mucus in the lungs. Robitussin DM is available in a variety of forms, including liquid, capsule, and tablet. While it is generally safe and effective when taken as directed, it is important to understand the proper dosage and potential side effects. This guide will provide an overview of Robitussin DM, including information about its uses, dosage, and potential side effects.
Robitussin DM is used to treat coughs and colds. The dextromethorphan in Robitussin DM helps suppress coughs, while the guaifenesin helps thin and loosen mucus in the lungs. Robitussin DM is available in a variety of forms, including liquid, capsule, and tablet. It is generally safe and effective when taken as directed.
Robitussin DM should be taken as directed on the package or as directed by a doctor. The recommended dose for adults and children over 12 years of age is two teaspoons (10 mL) every 4 to 6 hours, not to exceed 12 teaspoons (60 mL) in 24 hours. For children 6 to 12 years of age, the recommended dose is one teaspoon (5 mL) every 4 to 6 hours, not to exceed 6 teaspoons (30 mL) in 24 hours. For children under 6 years of age, Robitussin DM should not be used without consulting a doctor.
Robitussin DM is generally safe and effective when taken as directed. However, like all medications, it can cause side effects. Common side effects include nausea, vomiting, dizziness, drowsiness, and dry mouth. If these side effects persist or worsen, contact a doctor. Serious side effects are rare but can include difficulty breathing, chest tightness, and irregular heartbeat. If these side effects occur, seek medical help immediately.
Robitussin DM should not be taken by anyone who is allergic to any of its ingredients. It should also not be taken by anyone who has high blood pressure, heart disease, glaucoma, or an overactive thyroid. It should also not be taken by anyone who has taken a monoamine oxidase inhibitor (MAOI) in the past 14 days. Robitussin DM should not be taken by anyone who is pregnant or breastfeeding without consulting a doctor.
Robitussin DM can interact with certain medications, including MAOIs, sedatives, antidepressants, and other cough and cold medications. Before taking Robitussin DM, it is important to tell a doctor or pharmacist about all medications that are currently being taken.
Robitussin DM is a popular over-the-counter medication used to treat coughs and colds. It contains two active ingredients: dextromethorphan, an antitussive that helps suppress coughs, and guaifenesin, an expectorant that helps thin and loosen mucus in the lungs. Robitussin DM is generally safe and effective when taken as directed, but it is important to understand the proper dosage and potential side effects. This guide has provided an overview of Robitussin DM, including information about its uses, dosage, and potential side effects.
1.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
2.
Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice
3.
Childhood brain tumors develop early in highly specialized nerve cells, research reveals
4.
Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors
5.
For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.
1.
The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care
2.
Don't Ignore Your Vision Loss: What You Need to Know About Amaurosis Fugax
3.
Cancer Rates on the Rise: What Can We Do to Stop It?
4.
The Importance of Understanding Carboxyhemoglobin Levels in the Body: A Comprehensive Guide
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
2.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
5.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation